Author:
Melnikov M. V.,Kasatkin D. S.,Volkov A. I.,Boyko A. N.
Publisher
Media Sphere Publishing Group
Subject
Psychiatry and Mental health,Clinical Neurology
Reference35 articles.
1. Boyko AN, Davydovskaya MV, Demina TL, Lashch NYu, Ovcharov VV, Popova NF, Sidorenko TV, Sinbukhova NI, Trubachenko AV, Khachanova NV, Gusev EI. The experience of long-term use of betaferon and copaxone in the daily practice of neurologists is the results of 5 years of treatment of patients with multiple sclerosis in the Moscow city center of multiple sclerosis. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2007;107(4):84-94. (In Russ.)
2. Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis
3. Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results
4. A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis
5. Jain A, Jain SK. PEGylation: an approach for drug delivery. A review. Crit Rev Ther Drug Carrier Syst. 2008;25(5):403-447.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献